drugset / Trial / NCT00824512
Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The purpose of this protocol is to determine the efficacy of EGb 761 120 mg bid versus placebo in patients suffering from Friedreich Ataxia
Timeline
- Start
- 2008-06
- Primary completion
- 2011-10
- Completion
- 2011-10
Outcome
Missed primary endpoint
registry analysis (unspecified test); EGb 761® 120 mg vs Placebo; p = 0.9133 NCT00824512 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ginkgo Biloba Extract | Traditional medicine (herbal / TCM) | 120 mg | Oral |